Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 1206-1208, June 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drewinko, B.
Right arrow Articles by Barranco, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drewinko, B.
Right arrow Articles by Barranco, S. C.

The Response of Human Lymphoma Cells in Vitro to Bleomycin and 1,3-Bis(2-chloroethyl)-1-nitrosourea

Benjamin Drewinko, Judy K. Novak and S. C. Barranco

Departments of Clinical Pathology [B. D.] and Surgery [J. K. N., S. C. B.], The University of Texas, M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas 77025

Asynchronous human lymphoma cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea exhibited a broad-shouldered, threshold-type survival curve similar to that obtained after X-irradiation, suggesting that damage must be accumulated before killing effect is expressed. The sensitivity of the lymphoma cells to bleomycin was expressed as a biphasic dose-response survival curve, suggesting the involvement of sensitive and less sensitive fractions of cells. A 1000-fold reduction in survival was observed following treatment with bleomycin for the duration of one cell cycle.

Received 1/18/72. Accepted 3/ 6/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.